Taken together, these results indicated that escape from senescence in hypoxic CIS-treated lung cancer cells depended on the p53/p21 signaling pathway and the progression from the G2 phase to mitosis required activation of cyclin B. In addition, the EMT results suggested a role in escaping from senescence. The gene discussed is TP53; the disease is lung cancer.